April 2008 Vol 54 No 4
Treating erectile dysfunction in nonresponders to PDE5 inhibitors
By Neil H. Baum, MD, Tulane Medical School, New Orleans, LA
Ann Ezzell, BA, University of Tennessee College of Medicine, Memphis, TN
April 15th 2008Ann Ezzell, BA, University of Tennessee College of Medicine, Memphis, TN
ArticleResident and Staff
Most patients are successfully treated using PDE5 inhibitors, but if treatment failure occurs, physicians have many therapeutic options at their disposal; these options are outlined by the authors.
